Navigation Links
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Date:12/16/2013

,  which have been filed with the SEC and in the case of Valeant, the CSA. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the companies' actual results to differ materially from expected and historical results. The companies assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Additional Information and Where to Find It
The tender offer described in this release has not yet commenced and this release is not a recommendation or an offer to purchase or a solicitation of an offer to sell shares of Solta. At the time the tender offer is commenced Sapphire Subsidiary Corp. and Valeant will file a Tender Offer Statement on Schedule TO, containing an offer to purchase, form of letter of transmittal and related tender offer documents, with the SEC and Solta will file a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the tender offer with the SEC. Valeant and Solta intend to mail these documents to the stockholders of Solta. These documents, as they may be amended from time to time, will contain important information about the tender offer and stockholders of Solta are urged to read them carefully when they become available. Stockholders of Solta will be able to obtain a free copy of these documents, when they become available, at the website maintained by the SEC at www.sec.gov. In addition, the Tender Offer Statement and other documents that Valeant files with the SEC will be made available to all stockholders of Solta free of charge at www.valeant.com. The Solicitation/Recommendation Statement and the other documents filed by Solta with the SEC will be made available to all stockholders of Solta free of charge at www.Solta.com.'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 Elekta (NSE:EKTAb) and Royal Philips ... NHS Foundation Trust ( Manchester, UK ), ... mission is to develop the clinical value of an ... Such a system would, in principle, improve the practice ... "The Christie was an essential participant in ...
(Date:7/22/2014)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... of patients in its ongoing Phase 2 trial (Study ... the revised clinical protocol agreed to with the FDA ... Halozyme,s proprietary recombinant human hyaluronidase under development for the ... "Our diligent effort to rapidly re-initiate patient enrollment ...
(Date:7/22/2014)... July 22, 2014  Neurotrope Bioscience, Inc., a subsidiary ... exclusive license agreement with the Icahn School of Medicine ... Mount Sinai ) to utilize its proprietary information ... the treatment of Niemann-Pick Type C Disease (NPC), a ... Alzheimer-like symptoms. The license also covers other diseases and ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... DATATRAK International, Inc. (OTCQX: DATA), a technology and services ... trials industry, today announced that it has been awarded ... Organization (CRO) in India, with which the Company had ... order to execute a Phase II study for the ...
... 8, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... has granted orphan drug designation for tasimelteon, an oral ... for Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with ... the designation that the Committee for Orphan Medicinal Products ...
Cached Medicine Technology:DATATRAK Awarded First Study With Kreara Solutions 2DATATRAK Awarded First Study With Kreara Solutions 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 2Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 4
(Date:7/22/2014)... the University of Murcia have studied the changes ... a personality trait that causes difficulties in inhibiting ... and leads to unplanned actions without considering the ... indicator for predicting the risk of behavioural problems. ... the University of Murcia analyses whether the connectivity ...
(Date:7/22/2014)... CyraCom has been ranked as North ... translation and interpreting industry. Released June 2014 by the ... "The Language Services Market: 2014," also ranked CyraCom as ... up two spots from 2013. , In 2013, Common ... provide interpretation services – a subset of the language ...
(Date:7/22/2014)... 2014 The Muscular Dystrophy Association (MDA) and ... MUSCLE UP campaign that will raise funds to ... million Americans fighting muscle disease. , As part ... Jiffy Lube service centers through Sept. 1, 2014 to make ... make progress in the fight for muscle health. Since 2012, ...
(Date:7/22/2014)... The Restful Jaw Company announces its latest ... ®. The FDA-registered external device is clinically proven to ... fatigue and soreness during dental procedures. As such, patients ... do not need to take breaks or terminate procedures ... a vital solution in helping more than 31 million ...
(Date:7/22/2014)... Alan Mozes HealthDay Reporter ... drug already used to treat moderate-to-severe allergic asthma appears to ... helped by standard medications, new research suggests. The prescription ... hives, following U.S. Food and Drug Administration approval earlier this ... when Xolair is taken at a high dose for a ...
Breaking Medicine News(10 mins):Health News:Children's impulsive behaviour is related to their brain connectivity 2Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:Asthma Drug May Help Those With Chronic Hives 2Health News:Asthma Drug May Help Those With Chronic Hives 3
... Indian Railways handed over the new five state-of-the-art coach ... train, to Impact India Foundation here today. Speaking on ... said that since 1991, Impact India Foundation with the ... of cost to nearly 4,50,000 persons in remote and ...
... McCartney is pregnant again, just 7 months after giving birth to ... expecting her third child with husband Alasdhair Willis before the end ... legend dad Sir Paul McCartney is thrilled after hearing the news. ... has been getting him through the tough times. He would be ...
... tobacco industrys deceptive practices have been aggressively quashed through ... Ibrahim , co-author of an analysis in the August ... ,In the article, Ibrahim tracks the rise and ... for the past 40 years. She chronicles industry strategies ...
... structure of a key molecule called 'P2X receptor' that ... might lead to the development of painkillers for recurring ... by a team of researchers including Dr Chris Thompson, ... University of Manchester. ,Researchers examined slime moulds, ...
... the capacity of short-term memory is a strong predictor of ... ,A study conducted by them has shown that an ... time, but people with high IQ levels can remember more ... Vogel of the university conducted laboratory experiments to test their ...
... without fear of prosecution in one English city's pubs ... national ban, the local council admitted Wednesday . ... can spark up knowing that bureaucrats cannot impose the ... to get enforcement powers in time for July 1, ...
Cached Medicine News:Health News:New Lifeline Express Train Inaugurated 2Health News:Tobacco Industry Promotes Antismoking Campaigns 2Health News:Tobacco Industry Promotes Antismoking Campaigns 3Health News:Blunder Leaves Smoking Ban Up in Smoke in Stoke 2
Provides effective stretching of the plantar fascia and Achilles Tendon with bi-lateral dorsiflexion assist straps that allow the patient to adjust the degree of flexion to their individual requireme...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... to treat Achilles tendonitis and plantar fasciitis. Using ... and in back of the heel, the AirHeel ... reduce swelling and enhance circulation. The AirHeel is ... to apply just slip it on like ...
... of controlled compression and cold, the Foot ... anatomically designed cuff provides complete foot coverage ... as a single cuff, or with a ... disk). The Cooler is available separately and ...
Medicine Products: